| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Adams Eric A serves as a President &CEO at INM. Across recent SEC filings that breaks down to 5 buys and 0 sells. Those positions are worth an estimated $70K at current prices.
Historically, Adams Eric A's trades have earned a below-average insider score of 19/100 across 5 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -83.8%.
The biggest single holding is INM (~$70K) as President &CEO. Net of sales, the recent Form 4 record there shows accumulation of 84,520 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 41,600 | $0.36 | $14,921.92 | +1,763% | -13.3% | -55.7% | |
| Apr 14, 2022 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 14,160 | $0.89 | $12,659.04 | +31.6% | -50.9% | -94.3% | |
| Apr 13, 2022 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 8,560 | $0.85 | $7,276.00 | +23.6% | -47.8% | -94.4% | |
| Sep 29, 2021 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 8,800 | $1.73 | $15,224.00 | +32.0% | -25.8% | -87.4% | |
| Sep 28, 2021 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 11,400 | $1.75 | $19,984.20 | +70.9% | -22.5% | -87.2% |